natgillin/translations-raw huggingface dataset:
Ammonium dichromate meets the criteria for classification as carcinogenic (category 1B), mutagenic (category 1B) and toxic for reproduction (category 1B) in accordance with Regulation (EC) No 1272/2008 and therefore meets the criteria for inclusion in Annex XIV to Regulation (EC) No 1907/2006 set out in Article 57(a), (b) and (c) of that Regulation.
Amonijev dikromat izpolnjuje merila za razvrstitev kot rakotvoren (skupina 1B), mutagen (skupina 1B) in strupen za razmnoževanje (skupina 1B) v skladu z Uredbo (ES) št. 1272/2008, zato izpolnjuje tudi merila za vključitev v Prilogo XIV k Uredbi (ES) št. 1907/2006 v skladu s členom 57(a), (b) in (c) navedene uredbe.
Potassium chromate meets the criteria for classification as carcinogenic (category 1B) and mutagenic (category 1B) in accordance with Regulation (EC) No 1272/2008 and therefore meets the criteria for inclusion in Annex XIV to Regulation (EC) No 1907/2006 set out in Article 57(a) and (b) of that Regulation.
Kalijev kromat izpolnjuje merila za razvrstitev kot rakotvoren (skupina 1B) in mutagen (skupina 1B) v skladu z Uredbo (ES) št. 1272/2008, zato izpolnjuje tudi merila za vključitev v Prilogo XIV k Uredbi (ES) št. 1907/2006 v skladu s členom 57(a) in (b) navedene uredbe.
Sodium chromate meets the criteria for classification as carcinogenic (category 1B), mutagenic (category 1B) and toxic for reproduction (category 1B) in accordance with Regulation (EC) No 1272/2008 and therefore meets the criteria for inclusion in Annex XIV to Regulation (EC) No 1907/2006 set out in Article 57(a), (b) and (c) of that Regulation.
Natrijev kromat izpolnjuje merila za razvrstitev kot rakotvoren (skupina 1B), mutagen (skupina 1B) in strupen za razmnoževanje (skupina 1B) v skladu z Uredbo (ES) št. 1272/2008, zato izpolnjuje tudi merila za vključitev v Prilogo XIV k Uredbi (ES) št. 1907/2006 v skladu s členom 57(a), (b) in (c) navedene uredbe.
Those substances have been identified and included in the candidate list in accordance with Article 59 of Regulation (EC) No 1907/2006.
Navedene snovi so bile identificirane in vključene v seznam snovi v skladu s členom 59 Uredbe (ES) št. 1907/2006.
They have furthermore been prioritised for inclusion in Annex XIV to Regulation (EC) No 1907/2006 by the European Chemicals Agency (hereinafter ‘the Agency’) in its recommendation of 20 December 2011 [3] in accordance with Article 58 of that Regulation.
Evropska agencija za kemikalije (v nadaljnjem besedilu: Agencija) jim je v priporočilu z dne 20. decembra 2011 [3] v skladu s členom 58 Uredbe (ES) št. 1907/2006 dala prednost za vključitev v Prilogo XIV k navedeni uredbi.
It is therefore appropriate to include the substances in that Annex.
Zato jih je primerno vključiti v navedeno prilogo.
The cobalt compounds cobalt(II) sulphate, cobalt dichloride, cobalt(II) dinitrate, cobalt(II) carbonate and cobalt(II) diacetate meet the criteria for classification as carcinogenic (category 1B) and toxic for reproduction (category 1B) in accordance with Regulation (EC) No 1272/2008 and therefore meet the criteria for inclusion in Annex XIV to Regulation (EC) No 1907/2006 set out in Article 57(a) and (c) of that Regulation.
Kobaltove spojine, tj. kobaltov(II) sulfat, kobaltov diklorid, kobaltov(II) dinitrat, kobaltov(II) karbonat in kobaltov(II) diacetat, izpolnjujejo merila za razvrstitev kot rakotvorne (skupina 1B) in strupene za razmnoževanje (skupina 1B) v skladu z Uredbo (ES) št. 1272/2008, zato izpolnjujejo tudi merila za vključitev v Prilogo XIV k Uredbi (ES) št. 1907/2006 v skladu s členom 57(a) in (c) navedene uredbe.
They have been identified and included in the candidate list in accordance with Article 59 of Regulation (EC) No 1907/2006.
Snovi so bile identificirane in vključene v seznam snovi v skladu s členom 59 Uredbe (ES) št. 1907/2006.
Those cobalt compounds have also been prioritised for inclusion in Annex XIV to Regulation (EC) No 1907/2006 by the recommendation of the Agency of 20 December 2011 in accordance with Article 58 of that Regulation.
Agencija je v priporočilu z dne 20. decembra 2011 v skladu s členom 58 Uredbe (ES) št. 1907/2006 prednost za vključitev v Prilogo XIV k navedeni uredbi dala tudi navedenim kobaltovim spojinam.
However the Commission considers that at least one of the uses of those substances (i.e. surface treatment) poses a risk to human health that is not adequately controlled and needs to be addressed.
Vendar pa Komisija meni, da vsaj ena vrsta uporabe navedenih snovi (tj. površinska obdelava) predstavlja tveganje za zdravje ljudi, ki ni ustrezno nadzorovano in bi ga bilo treba obravnavati.
Therefore, in accordance with Article 69(1) of Regulation (EC) No 1907/2006, the Commission should ask the Agency to prepare a dossier in accordance with the requirements of Annex XV to that Regulation.
Komisija bi zato morala v skladu s členom 69(1) Uredbe (ES) št. 1907/2006 zaprositi Agencijo, da pripravi dokumentacijo, v skladu z zahtevami iz Priloge XV navedene uredbe.
It is therefore appropriate to postpone the decision on the inclusion of any of these substances in Annex XIV until after the process laid down in Articles 69 to 73 of that Regulation is concluded.
Zato je primerno preložiti odločitev o vključitvi katere koli od teh snovi v Prilogo XIV do zaključka postopka iz členov 69 do 73 navedene uredbe.
The Agency’s recommendation of 20 December 2011 has identified the latest application dates referred to in Article 58(1)(c)(ii) of Regulation (EC) No 1907/2006 for each of the substances listed in the Annex to this Regulation.
Priporočilo Agencije z dne 20. decembra 2011 določa zadnje datume uporabe iz člena 58(1)(c)(ii) Uredbe (ES) št. 1907/2006 za vsako snov iz Priloge k tej uredbi.
Those dates have been identified on the basis of the estimated time that would be required to prepare an application for the authorisation, taking into account the information available on the different substances and the information received during the public consultation carried out in accordance with Article 58(4) of Regulation (EC) No 1907/2006.
Navedeni datumi so bili določeni glede na predviden čas, potreben za pripravo vloge za avtorizacijo, ob upoštevanju razpoložljivih informacij o različnih snoveh in informacij, prejetih na javnih posvetovanjih, opravljenih v skladu s členom 58(4) Uredbe (ES) št. 1907/2006.
The Agency’s capacity to handle applications in the time provided for in the Regulation (EC) No 1907/2006 has also been taken into account.
Poleg tega je bila upoštevana zmogljivosti Agencije za obravnavanje vlog v predvidenem roku, določenem v Uredbi (ES) št. 1907/2006.
Concerning the seven chromium compounds, the Agency proposed the latest application date to be set at 21 months after entry into force of this Regulation.
Agencija je v zvezi s sedmimi kromovimi spojinami predlagala, da se datum njihove zadnje uporabe določi 21 mesecev po začetku veljavnosti te uredbe.
However, based on a discussion with Member States, a broader appreciation of the significance of the specific structure of the relevant markets and the related supply chains leads to the conclusion that the latest application date should be set at 35 months after entry into force of this Regulation.
Vendar pa bi bilo treba na podlagi razprave z državami članicami in ob širšem upoštevanju pomena posebne strukture zadevnih trgov in dobavnih verig datum zadnje uporabe določiti 35 mesecev po začetku veljavnosti te uredbe.
For each of the substances listed in the Annex to this Regulation the sunset date referred to in Article 58(1)(c)(i) of Regulation (EC) No 1907/2006 should be 18 months after the latest application date referred to in Article 58(1)(c)(ii) of that Regulation.
Za vsako snov iz Priloge k tej uredbi bi moral biti datum poteka iz člena 58(1)(c)(i) Uredbe (ES) št. 1907/2006 18 mesecev po datumu zadnje uporabe iz člena 58(1)(c)(ii) navedene uredbe.
It is appropriate to specify the dates referred to in points (i) and (ii) of Article 58(1)(c) of Regulation (EC) No 1907/2006 in Annex XIV to that Regulation.
V Prilogi XIV k Uredbi (ES) št. 1907/2006 je zato primerno določiti datume iz alinej (i) in (ii) člena 58(1)(c) navedene uredbe.
Article 58(1)(e) in conjunction with Article 58(2) of Regulation (EC) No 1907/2006 provides for the possibility of exemptions of uses or categories of uses in cases where there is specific Union legislation imposing minimum requirements relating to the protection of human health or the environment that ensures proper control of the risks.
Člen 58(1)(e) v povezavi s členom 58(2) Uredbe (ES) št. 1907/2006 določa možnost izvzetja uporab ali kategorij uporab, kadar posebna zakonodaja Unije določa minimalne zahteve v zvezi z varovanjem zdravja ljudi ali okolja za zagotovitev primernega nadzora tveganj.
Done at Brussels, 17 April 2013.
V Bruslju, 17. aprila 2013
Entry No
Vnos št.
EC No: 201-167-4
št. EC: 201-167-4
CAS No: 79-01-6
št. CAS: 79-01-6
21 October 2014
21. oktober 2014
21 April 2016
21. april 2016
EC No: 215-607-8
št. EC: 215-607-8
CAS No: 1333-82-0
št. CAS: 1333-82-0
Mutagenic
mutagen
21 March 2016
21. marec 2016
Acids generated from chromium trioxide and their oligomers
Kisline, pridobljene iz kromovega trioksida, in njihovi oligomeri
Group containing:
skupina vključuje:
Chromic acid
kromovo kislino
EC No: 231-801-5
št. EC: 231-801-5
CAS No: 7738-94-5
št. CAS: 7738-94-5
Dichromic acid
dikromovo kislino
EC No: 236-881-5
št. EC: 236-881-5
CAS No: 13530-68-2
št. CAS: 13530-68-2
Oligomers of chromic acid and dichromic acid
oligomere kromove in dikromove kisline
EC No: not yet assigned
št. EC: še ni določena
CAS No: not yet assigned
št. CAS: še ni določena
EC No: 234-190-3
št. EC: 234-190-3
CAS No: 7789-12-0
št. CAS: 7789-12-0
EC No: 231-906-6
št. EC: 231-906-6
CAS No: 7778-50-9
št. CAS: 7778-50-9
EC No: 232-143-1
št. EC: 232-143-1
CAS No: 7789-09-5
št. CAS: 7789-09-5
EC No: 232-140-5
št. EC: 232-140-5
CAS No: 7789-00-6
št. CAS: 7789-00-6
EC No: 231-889-5
št. EC: 231-889-5
CAS No: 7775-11-3
št. CAS: 7775-11-3
21 September 2017’
21. september 2017“
Commission Implementing Regulation (EU) No 349/2013
Izvedbena uredba Komisije (EU) št. 349/2013
Since the level of nullification or impairment and consequently of suspension has increased, the last product of the list in Annex II to Regulation (EC) No 673/2005 should be added to the list set out in Annex I to Regulation (EC) No 673/2005.
Ker se je raven razveljavitev ali omejitev in posledično začasnega preklica zvišala, je treba zadnji izdelek s seznama iz Priloge II k Uredbi (ES) št. 673/2005 dodati na seznam iz Priloge I k Uredbi (ES) št. 673/2005.
As a consequence, in accordance with Article 3(1)(e) of that Regulation, the Commission should amend the rate of the additional duty in order to adjust the level of suspension to the level of nullification or impairment.
Zato bi Komisija v skladu s členom 3(1)(e) navedene uredbe morala spremeniti stopnjo dodatne dajatve, da bi prilagodila stopnjo začasnega preklica obsegu razveljavitev ali omejitev.
The four products listed in Annex I should therefore be maintained on the list and the rate of additional import duty should be amended and set at 26 %.
Zato je štiri izdelke na seznamu v Prilogi I treba ohraniti na seznamu, stopnjo dodatne uvozne dajatve pa je treba spremeniti in jo določiti v višini 26 %.
The effect of a 26 % ad valorem additional import duty on imports from the United States of the products in Annex I represents, over one year, a value of trade that does not exceed USD 60774402.
Učinek dodatne uvozne dajatve ad valorem v višini 26 % na uvoz izdelkov iz Priloge I iz Združenih držav Amerike predstavlja v času enega leta vrednost trgovine, nižjo od 60774402 USD.
Article 6(1) and (2) of Regulation (EC) No 673/2005 contain specific exemptions from the additional import duty.
Člen 6(1) in (2) Uredbe (ES) št. 673/2005 navaja posebne izjeme, za katere dodatna uvozna dajatev ne velja.
Since the applicability of those exemptions is dependent on certain conditions being met before the entry into force or on the date of application of Regulation (EC) No 673/2005, the exemptions cannot in practice apply for imports of the new product added by this Regulation to the list in Annex I. Specific provisions should therefore be adopted to make these exemptions effective for imports of that product.
Ker je uporaba navedenih izjem odvisna od nekaterih pogojev, ki jih je treba izpolniti pred začetkom veljavnosti ali na datum začetka uporabe Uredbe (ES) št. 673/2005, se izjeme dejansko ne morejo uporabljati za uvoz novega izdelka, ki je s to uredbo dodan na seznam v Prilogi I. Zato je treba sprejeti posebne določbe, da bodo te izjeme veljale za uvoz navedenega izdelka.
To avoid circumvention of the additional duty, this Implementing Regulation should enter into force on the day of its publication.
Za preprečitev izogibanja dodatni dajatvi mora ta izvedbena uredba začeti veljati na dan objave.
An ad valorem duty of 26 % additional to the customs duty shall be imposed on the products originating in the United States of America listed in Annex I to Regulation (EC) No 673/2005.
Za izdelke s poreklom iz Združenih držav Amerike, navedene v Prilogi I k Uredbi (ES) št. 673/2005, se poleg carine uvede dajatev ad valorem v višini 26 %.
Products for which an import licence with an exemption from, or a reduction of duty, was issued before the date of entry into force of this Regulation shall not be subject to the additional duty provided they are classified under one of the following CN codes [2]: 62046231.
Za izdelke, za katere je bilo izdano uvozno dovoljenje z oprostitvijo ali znižanjem dajatve pred dnevom začetka veljavnosti te uredbe, se dodatne dajatve ne plačujejo, če so uvrščeni pod oznako KN [2]62046231.
Products for which it can be demonstrated that they are already en route to the European Union or in temporary storage or in a free zone or free warehouse or under a suspensive procedure within the meaning of Article 84(1)(a) of Council Regulation (EEC) No 2913/92 of 12 October 1992 establishing the Community Customs Code [3] on the date of application of this Regulation, and whose destination cannot be changed, shall not be subject to the additional duty provided they are classified under one of the following CN codes: 62046231.
Za izdelke, za katere je mogoče dokazati, da so bili na datum začetka uporabe te uredbe že na poti v Evropsko unijo, v začasni hrambi, prosti coni, prostem skladišču ali v odložnem postopku v smislu člena 84(1)(a) Uredbe Sveta (EGS) št. 2913/92 z dne 12. oktobra 1992 o carinskem zakoniku Skupnosti [3] in za katere namembnega kraja ni mogoče spremeniti, se dodatne dajatve ne plačujejo, če so uvrščeni pod oznako KN 62046231.
It shall apply from 1 May 2013.
Uporablja se od 1. maja 2013.
The description of products classified under these codes can be found in Annex I to Council Regulation (EEC) No 2658/87 (OJ L 256, 7.9.1987, p. 1), as replaced by Commission Regulation (EC) 1810/2004 (OJ L 327, 30.10.2004, p. 1), as amended by Regulation (EC) No 493/2005 (OJ L 82, 31.3.2005, p. 1).
Opis izdelkov, uvrščenih pod te oznake, je v Prilogi I k Uredbi Sveta (EGS) št. 2658/87 (UL L 256, 7.9.1987, str. 1), kakor je bila nadomeščena z Uredbo Komisije (ES) št. 1810/2004 (UL L 327, 30.10.2004, str. 1), kakor je bila spremenjena z Uredbo (ES) št. 493/2005 (UL L 82, 31.3.2005, str. 1).
The description of products classified under these codes can be found in Annex I to Regulation (EEC) No 2658/87.
Opis izdelkov, uvrščenih pod te oznake, je v Prilogi I k Uredbi (EGS) št. 2658/87.
The CDSOA disbursements for the most recent year for which data are available relate to the distribution of anti-dumping and countervailing duties collected during the Fiscal Year 2012 (1 October 2011 - 30 September 2012) as well as to the CDSOA additional 2012 distribution of anti-dumping and countervailing duties held during Fiscal Years 2006, 2007, 2008, 2009 and 2010, respectively.
Izplačila po CDSOA za zadnje leto, za katero so podatki na voljo, se nanašajo na razdelitev protidampinških in izravnalnih dajatev, pobranih v proračunskem letu 2012 (od 1. oktobra 2011 do 30. septembra 2012), kot tudi na dodatno razdelitev protidampinških in izravnalnih dajatev po CDSOA leta 2012, zadržanih v proračunskih letih 2006, 2007, 2008, 2009 oziroma 2010.
On the basis of the data published by the United States’ Customs and Border Protection, the level of nullification or impairment caused to the Union is calculated at USD 60774402.
Na podlagi podatkov, ki jih je objavila Carinska in mejna zaščita Združenih držav, je obseg razveljavitev ali omejitev, povzročenih Uniji, preračunan na 60774402 USD.
Corrigendum to Commission Implementing Regulation (EU) No 349/2013 of 17 April 2013 amending the rate of additional duty for products listed in Annex I to Council Regulation (EC) No 673/2005 establishing additional customs duties on imports of certain products originating in the United States of America
Popravek Izvedbene uredbe Komisije (EU) št. 349/2013 z dne 17. aprila 2013 o spremembi stopnje dodatne dajatve za izdelke iz Priloge I k Uredbi Sveta (ES) št. 673/2005 o vzpostavitvi dodatnih carin za uvoz nekaterih izdelkov s poreklom iz Združenih držav Amerike
(Official Journal of the European Union L 108 of 18 April 2013)
(Uradni list Evropske unije L 108 z dne 18. aprila 2013)
On page 8, Annex I should read as follows:
Stran 8, Priloga I se glasi:
The description of products classified under these codes can be found in Annex I to Council Regulation (EEC) No 2658/87 of 23 July 1987 on the tariff and statistical nomenclature and on the Common Customs Tariff as replaced by Commission Regulation (EC) No 1810/2004 as amended by Regulation (EC) No 493/2005.
Opis izdelkov, ki se uvrščajo pod te oznake, je v Prilogi I k Uredbi Sveta (EGS) št. 2658/87 z dne 23. julija 1987 o tarifni in statistični nomenklaturi ter skupni carinski tarifi, kakor je bila nadomeščena z Uredbo Komisije (ES) št. 1810/2004, kakor je bila spremenjena z Uredbo (ES) št. 493/2005.
OJ L 82, 31.3.2005, p. 1.’.
UL L 82, 31.3.2005, str. 1.“
Commission Implementing Regulation (EU) No 350/2013
Izvedbena uredba Komisije (EU) št. 350/2013
approving the active substance bixafen, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011
o odobritvi aktivne snovi biksafen v skladu z Uredbo (ES) št. 1107/2009 Evropskega parlamenta in Sveta o dajanju fitofarmacevtskih sredstev v promet in spremembi Priloge k Izvedbeni uredbi Komisije (EU) št. 540/2011
In accordance with Article 6(2) of Directive 91/414/EEC the United Kingdom received on 8 October 2008 an application from Bayer CropScience for the inclusion of the active substance bixafen in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Združeno kraljestvo 8. oktobra 2008 prejelo zahtevek družbe Bayer CropScience za vključitev aktivne snovi biksafen v Prilogo I k Direktivi 91/414/EGS.
Decision 2009/700/EC confirmed that the dossier was ‘complete’ in the sense that it could be considered as satisfying, in principle, the data and information requirements of Annexes II and III to Directive 91/414/EEC.
Z Odločbo 2009/700/ES je bilo potrjeno, da je dokumentacija „popolna“ v smislu načelnega izpolnjevanja zahtev po podatkih in informacijah iz prilog II in III k Direktivi 91/414/EGS.
The designated rapporteur Member State submitted a draft assessment report on 19 July 2011.
Država članica poročevalka je 19. julija 2011 predložila osnutek poročila o oceni.
The Authority presented to the Commission its conclusion on the review of the pesticide risk assessment of the active substance bixafen [4] on 15 October 2012.
Agencija je 15. oktobra 2012 Komisiji predložila sklep o pregledu ocene tveganja pesticidov z aktivno snovjo biksafen [4].
The draft assessment report and the conclusion of the Authority were reviewed by the Member States and the Commission within the Standing Committee on the Food Chain and Animal Health and the draft assessment report was finalised on 15 March 2013 in the format of the Commission review report for bixafen.
Osnutek poročila o oceni in sklep Agencije so države članice in Komisija pregledale v Stalnem odboru za prehranjevalno verigo in zdravje živali ter končno različico osnutka poročila o oceni pripravile 15. marca 2013 v obliki poročila Komisije o pregledu biksafena.
It has appeared from the various examinations made that plant protection products containing bixafen may be expected to satisfy, in general, the requirements laid down in Article 5(1)(a) and (b) and Article 5(3) of Directive 91/414/EEC, in particular with regard to the uses which were examined and detailed in the Commission review report.
Različne preiskave so pokazale, da se za fitofarmacevtska sredstva, ki vsebujejo biksafen, lahko pričakuje, da na splošno izpolnjujejo zahteve iz člena 5(1)(a) in (b) ter člena 5(3) Direktive 91/414/EGS, zlasti pri uporabah, ki so bile proučene in podrobno navedene v poročilu Komisije o pregledu.
It is therefore appropriate to approve bixafen.
Zato je primerno, da se biksafen odobri.
Member States should be allowed a period of six months after approval to review authorisations of plant protection products containing bixafen.
Državam članicam bi bilo treba omogočiti, da v šestih mesecih po odobritvi pregledajo registracije fitofarmacevtskih sredstev, ki vsebujejo biksafen.
In order to avoid further difficulties it therefore appears necessary to clarify the duties of the Member States, especially the duty to verify that the holder of an authorisation demonstrates access to a dossier satisfying the requirements of Annex II to that Directive.
Da bi se izognili nadaljnjim težavam, se zato zdi nujno razjasniti obveznosti držav članic, zlasti obveznost, da preverijo, ali ima imetnik registracije dostop do dokumentacije, ki izpolnjuje zahteve iz Priloge II k navedeni direktivi.
The active substance bixafen, as specified in Annex I, is approved subject to the conditions laid down in that Annex.
Aktivna snov biksafen, kot je opredeljena v Prilogi I, se odobri v skladu s pogoji iz navedene priloge.
Member States shall in accordance with Regulation (EC) No 1107/2009, where necessary, amend or withdraw existing authorisations for plant protection products containing bixafen as an active substance by 31 March 2014.
Države članice v skladu z Uredbo (ES) št. 1107/2009 do 31. marca 2014 po potrebi spremenijo ali prekličejo veljavne registracije fitofarmacevtskih sredstev, ki vsebujejo biksafen kot aktivno snov.
By that date they shall in particular verify that the conditions in Annex I to this Regulation are met, with the exception of those identified in the column on specific provisions of that Annex, and that the holder of the authorisation has, or has access to, a dossier satisfying the requirements of Annex II to Directive 91/414/EEC in accordance with the conditions of Article 13(1) to (4) of that Directive and Article 62 of Regulation (EC) No 1107/2009.
Do navedenega datuma zlasti preverijo, ali so pogoji iz Priloge I k tej uredbi izpolnjeni, razen pogojev iz stolpca o posebnih določbah v navedeni prilogi, in ali ima imetnik registracije dokumentacijo ali dostop do dokumentacije, ki izpolnjuje zahteve iz Priloge II k Direktivi 91/414/EGS v skladu s pogoji iz člena 13(1) do (4) navedene direktive ter člena 62 Uredbe (ES) št. 1107/2009.